case studies

Advancing Therapies for Children with Rare Heart Disease

Mezzion_logo

Mezzion Pharmaceuticals

the challenge

An estimated 35,000 patients in the United States are born with a single ventricle — one of the most complex heart defects. Currently, there are no FDA-approved therapies available for this patient population. Mezzion is conducting a Phase 3 clinical trial to evaluate whether its treatment can preserve and extend cardiac function. CURA has partnered with Mezzion to elevate their presence in the congenital heart disease community to strengthen their credibility and accelerate trial recruitment.

The Solution

FDA image

Conducted a virtual FDA patient listening session with the Center for Drug Evaluation and Research

Laptop Image

Created a dedicated landing page and established an IRB-compliant referral pathway to connect interested patients with their nearest trial site

IMG_6714

Coordinated provider engagement events, including large-scale receptions and dinners. Managed medical meeting presence to strengthen relationships with leading researchers and clinicians

envato-labs-image-edit (6)

Launched a paid digital campaign, hyper-targeted to individuals with online affiliations and search histories tied to single-ventricle heart disease

IMG_3208

Managed advocacy relationships and sponsorships to broaden clinical trial visibility

The Results

13% increase in stock price

the week of the trial website launch during Pediatric Cardiology World Congress in D.C.

envato-labs-image-edit (2)
6 patient and provider organizations

engaged through partnerships, sponsorships and MOUs

MezzionImage9
574,000 visitors

driven to FUEL2study.com since the site launch

envato-labs-image-edit (4)
22 trial participants

recruited under narrow eligibility criteria, representing 10% of total enrollment, outperforming many of the 30 individual trial sites

envato-labs-image-edit (5)
6.8 million impressions

and 208,000 clicks generated through FUEL-2 digital ad campaigns

Key Services

Clinical trial recruitment Content development & design Digital marketing & paid media Social media Stakeholder engagement Strategic Communications Planning Thought leadership Website development & support
View More Services

"CURA has been a game changer for Mezzion in the rare congenital heart disease space, opening doors to top advocacy groups, providing creative marketing strategies and content that resonates with patients and providers, navigating and engaging the FDA and being core to clinical trial recruitment.”

John Presser, MBA,Chief Business Officer
Mezzion Pharmaceuticals
Let's get started

Ready to Transform Health Care?

Contact Us